Results 131 to 140 of about 408,319 (335)
Secondary malignant tumors in surviving patients with neuroblastoma. The experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology [PDF]
, 2023 D. T. Utalieva +7 more
openalex +1 more source
Arthritis Care &Research, EarlyView.Objective Cognitive impairment (CI) is common in patients with systemic lupus erythematosus (SLE). Despite its prevalence, the immune mechanisms are not well understood. We previously reported elevated serum levels of S100A8/A9 and matrix metalloproteinase 9 (MMP‐9) in patients with SLE and CI.
Carolina Muñoz‐Grajales +18 more
wiley +1 more source
The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response
OncoImmunologyIL-37 is a member of the IL-1 superfamily exerting anti-inflammatory functions in a number of diseases. Extracellular IL-37 triggers the inhibitory receptor IL-1R8 that is known to regulate different NK cell pathways and functional activities including ...
Nadine Landolina +8 more
doaj +1 more source
Galactomannan Downregulates the Inflammation Responses in Human Macrophages via NFκB2/p100
Mediators of Inflammation, 2015 We show that galactomannan, a polysaccharide consisting of a mannose backbone with galactose side groups present on the cell wall of several fungi, induces a reprogramming of the inflammatory response in human macrophages through dectin-1 receptor.
Víctor Toledano +9 more
doaj +1 more source
Corrigendum: Lipid metabolism in tumor immunology and immunotherapy. [PDF]
Front Oncol, 2023 Duong LK +8 more
europepmc +1 more source
Addressing current challenges in cancer immunotherapy with mathematical and computational modeling
, 2017 The goal of cancer immunotherapy is to boost a patient's immune response to a tumor. Yet, the design of an effective immunotherapy is complicated by various factors, including a potentially immunosuppressive tumor microenvironment, immune-modulating ...
Adler, Adam J. +3 more
core +1 more source
Arthritis Care &Research, Accepted Article.Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source
Lipid metabolism in tumor immunology and immunotherapy. [PDF]
Front Oncol, 2023 Duong LK +8 more
europepmc +1 more source
CD8+ T‐cell memory in tumor immunology and immunotherapy [PDF]
, 2006 Christopher A. Klebanoff +2 more
openalex +1 more source